CDSCO proposes the Draft New Drugs and Clinical Trials (Amendment) Rules, 2021; invites objections/suggestions by 14th September, 2021 by Lexplosion | Aug 5, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Department of Commerce restricts the export of Remdesivir Injection & Remdesivir Active Pharmaceutical Ingredients (API) ; no separate export authorization will be required by Lexplosion Solution | Jun 17, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
NCT, Delhi orders authorized dealers of pulse Oxymeter and Oxygen Concentrator to display the Stock position and MRP of these devices at their premises for general public by Lexplosion Solution | May 28, 2021 | Delhi, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Govt. prohibits the export of injection Remdesivir and Remdesivir API with immediate effect; all domestic manufacturers of Remdesivir directed to display details of their stockists / distributors on their websites by Lexplosion | Apr 13, 2021 | Central, OPS, PharmaceuticalsYou need to be logged in to view this content. Please Log In. Not a Member? Join... Read More
Govt. notifies the Production Linked Incentive Scheme for Pharmaceuticals ; states the eligibility & Approval and Disbursement Process under the Scheme by Lexplosion | Mar 8, 2021 | Central, OPS, PharmaceuticalsThe Ministry of Chemicals and Fertilizers (“Ministry”) has, through a Gazette Notification dated... Read More
Haryana Govt. revises rates for RTPCR testing; applicable to private laboratories in the State by Lexplosion | Dec 19, 2020 | Haryana, Industry Specific, OPS, Pharmaceuticals, Private LaboratoriesIn continuation to its previous orders, the Department of Health and Family Welfare, Haryana... Read More
